Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Medical Oncology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
J Genet Couns. 2023 Aug;32(4):778-787. doi: 10.1002/jgc4.1687. Epub 2023 Feb 7.
Clinical and familial factors predict psychological distress after genetic testing for cancer susceptibility. However, the contribution of an individual's psychological background to such distress is unclear. This study aims to analyze the psychological impact of genetic testing and to identify the profile of individuals at higher risk. This is a longitudinal multicenter study of individuals undergoing genetic testing for cancer susceptibility. Demographic, clinical, genetic, familial, and psychological (personality types, cancer worry) characteristics were assessed by validated questionnaires the day of genetic testing. Distress, uncertainty, and positive experience perception (MICRA scale) were evaluated at the results disclosure visit, and 3 and 12 months afterwards. Multivariate analysis was performed. A total of 714 individuals were included. A high neuroticism score, high baseline cancer worry, and a positive genetic test result were independently associated with higher psychological impact (p-value < 0.05). The highest risk profile (10% of the cohort) included women with high level of neuroticism and a positive result. Uncertainty was mainly associated with a high level of neuroticism, regardless of the genetic test result. A holistic approach to personalized germline genetic counseling should include the assessment of personality dimensions.
临床和家族因素可预测癌症易感性基因检测后的心理困扰。然而,个体心理背景对此类困扰的贡献尚不清楚。本研究旨在分析基因检测的心理影响,并确定具有更高风险的个体特征。这是一项针对癌症易感性基因检测个体的纵向多中心研究。通过经过验证的问卷在基因检测当天评估人口统计学、临床、遗传、家族和心理(人格类型、癌症担忧)特征。在结果披露访问时以及 3 个月和 12 个月后评估困扰、不确定性和积极体验感知(MICRA 量表)。进行了多变量分析。共纳入 714 人。高神经质评分、高基线癌症担忧和阳性基因检测结果与更高的心理影响独立相关(p 值<0.05)。最高风险特征(队列的 10%)包括神经质水平高且检测结果阳性的女性。无论基因检测结果如何,不确定性主要与神经质水平高有关。个性化种系遗传咨询的整体方法应包括人格维度的评估。